参考文献/References:
[1] WOLTERS F J, IKRAM M A. Epidemiology of vascular dementia[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2019, 39(8): 1542-1549.
[2] IADECOLA C, DUERING M, HACHINSKI V, et al. Vascular cognitive impairment and dementia: JACC scientific expert panel[J]. Journal of the American College of Cardiology, 2019, 73(25): 3326-3344.
[3] WANG Peng, ZHAO Yipeng, LI Yixin, et al. Sestrin2 overexpression attenuates focal cerebral ischemic injury in rat by increasing Nrf2/HO-1 pathway-mediated angiogenesis[J]. Neuroscience, 2019, 410: 140-149.
[4] 蔡文灿, 刘熙君, 刘彦明, 等. 血清PLGF 和sFLT-1水平联合检测对急性ST 段抬高型心肌梗死患者PCI 术后MACE 复发的诊断价值研究[J]. 现代检验医学杂志, 2021, 36(2): 66-69. CAI Wencan, LIU Xijun, LIU Yanming, et al. Combined detection of serum PLGF and SFLT-1 levels in the diagnosis of MACE recurrence after PCI in patients with acute ST-segment elevation myocardial infarction[J]. Journal of Modern Laboratory Medicine, 2021, 36(2): 66-69.
[5] 贾建平, 陈生弟, 崔丽英, 等. 神经病学[M]. 7版.北京:人民卫生出版社, 2013:217-222. JIA Jianping, CHEN Shengdi, CUI Liying. Neurology[M]. 7th Ed. Beijing: People’s Medical Publishing House, 2013: 217-222.
[6] 亚拉盖, 图雅, 吉仁巴雅, 等. 血清NGF, BDNF,GFAP 水平与老年血管性痴呆严重程度的相关性分析[J]. 现代生物医学进展, 2019, 19(14): 2703-2706. YA Lagai, TU Ya, JI Renbaya, et al. Correlative analysis of serum NGF, BDNF and GFAP levels with the severity of senile vascular dementia[J]. Progress in Modern Biomedicine, 2019, 19(14): 2703-2706。
[7] 郝美美, 李晨曦. 血清Livin, IFN-γ 水平在血管性痴呆患者中的变化及其临床意义[J]. 卒中与神经疾病, 2018, 25(6): 668-671, 680. HAO Meimei, LI Chenxi. The changes and its clinical significance of serum Livin, IFN-γ in patients with vascular dementia[J]. Stroke and Nervous Diseases, 2018, 25(6): 668-671, 680.
[8] BIR S C, KHAN M W, JAVALKAR V, et al. Emerging concepts in vascular dementia: a review[J]. Journal of Stroke and Cerebrovascular Diseases, 2021, 30(8): 105864.
[9] HASE Y, JOBSON D, CHEONG J, et al. Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion[J]. Acta Neuropathologica Communications, 2024, 12(1): 29.
[10] 王红艳, 何海艳, 王玉川, 等. 血管性痴呆动物模型及病理机制研究进展[J]. 药物资讯, 2020, 9(2): 71-77. WANG Hongyan, HE Haiyan, WANG Yuchuan, et al. Research progress of vascular dementia in animal model and pathology[J]. Pharmacy Information, 2020, 9(2): 71-77.
[11] 陈静, 陈炜, 伍媛, 等. 中药有效成分多靶点调控治疗血管性痴呆的研究进展[J]. 广西医学, 2019,41(18): 2363-2365. CHEN Jing, CHEN Wei, WU Yuan, et al. Advances in multi-target mediation using active components of Chinese medicine for management of vascular dementia[J]. Guangxi Medical Journal, 2019, 41(18): 2363-2365.
[12] 杜双霞, 张晓红, 苑艳尊, 等. 血清氧化应激水平与血管性痴呆患者认知功能、神经损伤因子水平及预后的关系[J]. 山东医药, 2022, 62(5): 67-70. DU Shuangxia, ZHANG Xiaohong, YUAN Yanzun, et al. Relationship of serum oxidative stress level and cognitive function, nerve injury factors level and prognosis in patients with vascular dementia[J]. Shandong Medical Journal, 2022, 62(5): 67-70.
[13] 段新飞, 宋利宏, 胡科, 等. 血管性痴呆大鼠氧化应激、炎症反应与SIRT1 的相关性研究[J]. 精神医学杂志, 2020, 33(2): 122-125. DUAN Xinfei, SONG Lihong, HU Ke, et al. Correlation between oxidative stress, inflammatory response and SIRT1 in vascular dementia rats[J]. Journal of Psychiatry, 2020, 33(2): 122-125.
[14] ZHANG Jianbin, ZHANG Qianren, JIN Qian, et al. Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis[J]. Molecular Metabolism, 2024, 80: 101865.
[15] CHE Xiaojing, CHAI Jiagui, FANG Yan, et al. Sestrin2 in hypoxia and hypoxia-related diseases[J]. Redox Report, 2021, 26(1): 111-116.
[16] 王迪, 啜红斐. 血清Sestrin2 水平与急性脑梗死患者氧化应激反应及早期神经功能恶化的关系[J]. 实用临床医药杂志, 2022, 26(6): 14-17, 22. WANG Di, CHUAI Hongfei. Correlations of serum Sestrin2 level with oxidative stress response and early deterioration of neurological function in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2022, 26(6): 14-17, 22.
[17] 雷晓鹏, 张泽平. 可溶性Fms 样酪氨酸激酶-1 预测急性颅脑损伤蛛网膜下腔出血后脑血管痉挛的研究[J]. 卒中与神经疾病, 2019, 26(4): 427-430, 434. LEI Xiaopeng, ZHANG Zeping. The study on the predictive effect of soluble Fms-like tyrosine kinase 1 on cerebral vasospasm after subarachnoid hemorrhage in acute craniocerebral injury[J]. Stroke and Nervous Diseases, 2019, 26(4): 427-430, 434.
[18] LIAO Li, ZHAO Xingtao, ZHOU Mengting, et al. sFlt-1: A double regulator in angiogenesis-related diseases[J]. Current Pharmaceutical Design, 2021, 27(40): 4160-4170.
[19] DRAKER N, TORRY D S, TORRY R J. Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review[J]. Biomarkers in Medicine, 2019, 13(9): 785-799.
[20] 吕霞, 周小燕, 焦黛妍. 血清sCAM-1, IGF-1 和sFlt-1 对自发性蛛网膜下腔出血后脑血管痉挛的病情与预后评估的价值[J]. 河北医药, 2022, 44(8):1194-1197. L? Xia, ZHOU Xiaoyan, JIAO Daiyan. The predictive and evaluation value of serum SCAM-1, IGF-1 and sFLT-1 levels in cerebral vasospasm after spontaneous subarachnoid hemorrhage[J]. Hebei Medical Journal, 2022, 44(8): 1194-1197.